Metronomic Oral Vinorelbine Plus Anti-PD-L1/Anti-CTLA4 ImmunothErapy in Patients With Advanced Solid Tumours

Clinical trial NCT03518606 · COMPLETED

Trial details

NCT number: NCT03518606
Sponsor: UNICANCER
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Solid Tumours Breast Cancer Head and Neck Cancer Cervix Cancer Prostate Cancer

Start date: 2018-06-20
Primary completion: 2022-04-01
Enrollment: 126

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.